FDA+ roundup: Medicare spends billions on unconfirmed accelerated approvals — study; EMA appoints new CMO
New research published in JAMA Health Forum dives into the numbers on how much CMS spent on drugs winning approval via …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
